The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

Withdrawn

• Conditions: Preeclampsia; Pregnancy

• Registration Number: NCT01179542
• Lead Sponsor: Meir Medical Center

Brief Summary

The involvement of eukaryotic translation initiation factor 4E (eIF4E) in human placental implantation and in the pathological pregnancies: preeclampsia and IUGR.

Detailed Description

4 groups

Study Timeline

• Status Verified: 2010-08
• Study First Submitted: 2010-08-10
• Study First Submitted QC: 2010-08-10
• Study First Posted: 2010-08-11
• Study Start: 2010-09
• Primary Completion: 2012-10
• Study Completion: 2012-10
• Last Update Submitted: 2017-09-12
• Last Update Posted: 2017-09-13

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

• post TOP or DELIVERY

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
measure the Translation Initiation effect of experimental variables observational studies	2 years